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ABSTRACT
An Integrative and Comparative Analysis of Transcriptome and Targetome Data of
Medulloblastoma
Blaine Nelson
Director: Dan Van Peursem, Ph.D.

Medulloblastoma (MB) arises in the cerebellum and is the most common brain
tumor seen in the field of pediatrics. Primary and recurrent MBs are often found to
contain deregulated Atonal Homolog 1 (ATOH1) expression among SHH/PTCH signals.
Therefore, mice models were generated for research by inducing expression of the Atoh1
transgene in the cerebellum of Ptch1+/- mice. The overexpression of the Atoh1 transgene
in the animals transform the non-metastatic brain tumor to a metastatic tumor that
disseminates to the spinal cord and other parts of the brain. In order to understand the
molecular and cellular events involved in the cascade of metastatic MB, statistical
analysis of the transcriptome and targetome were applied. RNA-Sequencing was run first
to generate a common list of shared differentially expressed genes and then followed by
the addition of chromatin immunoprecipitation sequencing. From the data obtained,
pathway analysis was applied. The data from the mice were then subject to comparison to
a cohort of human data on MB to further investigate the similarities and differences in the
biological causes for the formation of the disease.
Das Medulloblastom entstammt im Kleinhirn und ist der häufigste pädiatrische
Gehirntumor. Es wird häufig festgestellt, dass primäre und rezidivierende
Medulloblastome deregulierte atonale Homolog 1 (ATOH1)-Expression unter SHHPTCH-Signalen enthalten. Darum wurden Mäusemodelle in der Forschung erstellt, indem
die Expression des Atoh1-Transgens im Kleinhirn von Ptch1+/ - Mäusen induziert wurde.
Die Überexpression dieses Transgens in den Tieren wandelt den gutartigen Gehirntumor
in einen metastatischen Tumor um, der sich auf das Rückenmark und andere Teile des
Gehirns verbreitet. Um die molekularen und zellulären Ereignisse nachzuvollziehen, die
an der Kaskade metastatisches Medulloblastoms beteiligt sind, wurden statistische
Analysen des Transkriptoms und des Targetoms durchgeführt. Die RNA-Sequenzierung
wurde zuerst durchgeführt, um eine gemeinsame Liste von differentiell exprimierten
Genen zu erstellen, gefolgt von dem Zusatz der ChromatinImmunopräzipitationssequenzierung. Von den erhaltenen Daten wurde eine Weganalyse
durchgeführt. Die Daten der Mäuse wurden dann einem Vergleich mit einer Kohorte
menschlicher Daten zum MB unterzogen, um die Ähnlichkeiten und Unterschiede in den
biologischen Ursachen für die Entstehung der Krankheit weiter zu untersuchen.
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I. Introduction
Medulloblastoma (MB) constitutes nearly 20% of all childhood brain tumors making it
the most common pediatric brain malignancy. MB stems from the posterior fossa, a region of
the brain located at the base of the skull, or more specifically within the cerebellum, which is the
part of the posterior fossa controlling coordination and balance (St. Jude, 2019). The malignant
tumor disseminates through the cerebrospinal fluid (CSF) to the area of the meninges and
subarachnoid space sheathing the brain and spinal cord termed the leptomeninges.
Leptomeningeal metastases, which are often discovered at the time of diagnosis or during
recurrence, are associated with a poor clinical prognosis. In order to treat the tumor, an
aggressive treatment plan including the use of surgery, craniospinal radiation, chemotherapy, or
a combination of the aforementioned is used to resect or destroy the malignancy; however, in
spite of the aggressive treatments, improvement in the survival of patients with the metastatic
1

disease has progressed slowly, which may be due to the expanse and intricacy of the condition.
This cancerous tumor is further categorized into one of four molecular subgroups, each of which
are based on different types of gene mutations and are distinguished from one another by their
aberrations, transcriptional profiles, and clinical outcomes. These subgroups that compose the
entirety of medulloblastoma include: wingless (WNT), Sonic Hedgehog (SHH), Group 3, and
Group 4; however, little is known about the last two groups. While each subgroup of
medulloblastoma is distinct from one another, the extent of the effects on the cellular
mechanisms resulting in medulloblastoma formation is not clear. It is important to explore the
molecular and cellular events involved in the ATOH1-driven cascade of metastatic MB so that
potential therapeutics may be safer and more effective, assuring that there will be no
detrimental effects on the developing brain.

II. Methods
II.1 Overview
A previous study performed by Sanford Research has shown that Atonal homolog 1
(ATOH1) not only plays a vital role in normal development of the cerebellum, but also plays a
critical role for murine models in the initiation and progression of MB in the SHH subgroup. The
research demonstrated an acceleration of MB development in mice with the protein patched
homolog 1 gene (Ptch1+/-) when Atoh1 expression was induced, transforming the benign tumors
into highly metastatic tumors. Further research for the transgenic overexpression of Atoh1 in
different mice strains has been conducted by Sanford Research to understand the role of Atoh1
in leptomeningeal dissemination and metastasis.
Dr. Haotian Zhao, a former researcher in the Sanford Health’s Research Center at
Sanford Research now located at the New York Institute of Technology, provided the gene
2

expression profiles with a set of 22,557 genes for statistical analysis of the mice models. There
were three strains of mice taken into account for this project in order to investigate the
molecular cascade of MB. These strains include medulloblastomas from transgenic mice with an
overexpression of Atoh1 and Ptch1+/- and thus present with a metastatic tumor (these mice are
designated with a T), mice with overexpressed Ptch1+/- only (these mice are designated with a P),
and the control group, or wild-type mice (designated with a C). Each strain of mice had three
replicates, ensuring validity and accounting for error that may have arisen during a trial.
In this study, functional genomic statistical analyses of RNA-Sequencing (RNA-Seq) and
chromatin immunoprecipitation sequencing (ChIP-Seq) data from the obtained gene expressions
values from Sanford were run and applied to uncover differentially expressed genes (DEGs) of
the MB SHH subgroup in the mice models. By doing such procedures, we are able to unveil the
cellular and molecular mechanisms involved in MB formation. RNA-Seq is biomedically relevant
as this sequencing is used to interpret the function of the genome as well as to understand how
the disease develops at the level of gene expression, otherwise known as the transcriptome.
Meanwhile, ChIP-Seq was applied to reveal the DNA binding sites of the transcription factors
and ultimately the gene regulation events. ChIP-Seq allowed us to assess the targetome, or all
the microRNA targets of an organism. The results of the targetome and transcriptome were
compared and integrated, and enriched pathways were detected and analyzed using Ingenuity
Pathway Analysis (QIAGEN®, 2017).
We applied multiple RNA-Seq statistical analysis tools using R to identify the significant
DEGs from the data. The tools used include baySeq (Hardcastle et al, 2010), Cuffdiff (Trapnell,
2017), DESeq (Anders et al, 2010), edgeR (McCarthy et al, 2012), limma (Ritchie et al, 2015), and
PoissonSeq (Li, 2011).
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II.2 baySeq
The Bioconductor package baySeq uses empirical Bayesian methods to identify
differential expression in high-throughput data. This package is able to find the identification for
differential expression by calculating estimated differential expression posterior likelihoods
(Hardcastle, 2009). This method assumes a negative binomial distribution and estimates priors.
BaySeq begins by defining the set of data in terms of similarities and differences between the
samples and their replicates. For a given set of data, baySeq then seeks to analyze which
samples behave similar to one another and which sets of samples behave identifiably different.
Because baySeq uses numerical methods with an empirical Bayesian approach, this allowed the
real data to be retained and the library size to be used as a scaling factor. The library size can be
defined as the total number of mapped reads during a run of data (Hardcastle et al, 2010). As a
package, baySeq is not intended for use with normalized data; therefore, raw count data were
used as the input. The samples were then paired up with one another [ex: the control group
with the overexpressed Ptch1+/- group (CP), the control group with the mice who have the
metastatic tumor (CT), and the overexpressed Ptch1+/- group with the mice who have the
metastatic tumor (TP)] in order to investigate the differences and similarities between gene
expression. Each replicate of the same sample [ex: C1, C2, C3] share the same set of underlying
parameters, but the sets of parameters between two different samples are not identical,
allowing for pairwise comparison.

II.3 Cuffdiff
Not only does Cuffdiff find differently expressed genes and transcripts through
substantial changes in the expression of the transcript, splicing, and promoter use, but the
program also finds genes being differentially regulated at the level of transcription. The program
4

identifies genes that are differentially regulated at the transcriptional level by grouping
transcripts into groups of biological meaning. In order to find which genes or transcripts are
differentially expressed, Cuffdiff tests the expression of an observed log-fold change against that
of the null hypothesis with no change; however, Cuffdiff must also measure the significance of
comparison because an observed change that is nonzero may occur on the behalf of variability
within both technical and cross-replicate biological aspects though the gene or transcript is not
actually differentially expressed (Trapnell, 2014). This package takes SAM files that contain data
from two or more samples as the input. By accepting and analyzing the data from two or more
biological conditions, Cuffdiff aids in the exploration of transcriptional regulation under differing
conditions (Ghosch et al, 2016).

II.4 DESeq
DESeq is another Bioconductor package. This package is able to estimate variance-mean
dependence using raw count data from high-throughput sequencing assays. Like baySeq, DESeq
also uses a negative binomial distribution to test for differential expressions (Anders et al, 2010);
however, while DESeq does make the assumption of negative binomial distribution, the package
also adds an assumption that there is a local linear relationship between the mean expression
levels and an over-dispersion of the data (Hardcastle et al, 2010). With DESeq, digital gene
expression analysis is performed on raw read counts, not transformed or normalized data for
sequencing depth. If anything other than raw read counts is used, nonsensical results may
occur; therefore, raw count data were used as the input. Comparisons between the different
conditions were run using the respective codes and then analyzed.
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II.5 edgeR
Another tool that was utilized in this project to discover DEGs was edgeR, which is
described as an empirical analysis of DGE in R. This program was designed for analyzing
expression data of replicated counts. EdgeR is able to find changes between two or more groups
by implementing a large quantity of statistical methodologies as long as one of the groups has a
phenotypical or experimental condition that has been replicated (Robinson et al, 2010). These
methodologies are based on a negative binomial distribution and include but are not limited to
an empirical Bayes estimation, exact tests, generalized linear models, and quasi-likelihood tests.
The quasi-likelihood tests account for the uncertainty in the dispersion estimation and thus, give
this package a stronger and firmer control on error rates (Chen et al, 2019). Currently, pairwise
comparisons are supported by edgeR to test for differential expression. We therefore had to
specify which two groups we were going to compare at a time, though the end result was still a
comparison between CP, CT, and TP. When keyed into the statistical tool, rows of the data
corresponded to genes, while the columns corresponded to the independent libraries, or the
replicates. Just like the other packages, raw read counts were used as the original input.

II.6 limma
As a Bioconductor software tool, limma analyzes data from a variety of platforms. These
include experiments that involve microarrays, protein arrays, and high-throughput polymerase
chain reaction (PCR). Rather than breaking the treatments down individually and then making
piece by piece comparisons between pairs of samples, limma analyzes experiments on an
integrated whole level using linear models (Ritchie et al, 2015). This approach is useful as the
technique provides us the ability to model correlations that may exist between samples with
differences in their transcriptome. Limma also has the unique ability to incorporate quantitative
6

weights into all its levels of analysis. Power to detect differently expressed genes is increased
with the usage of weights. RNA-seq read counts are able to be analyzed through limma with
high precision. This works through the function voom, which converts the read counts that have
been processed to the log-scale, thus estimating the mean-variance relationship in an empirical
fashion (Ritchie et al, 2015). Because this software package accepts RNA-seq data in the form of
a matrix and thus operates on a matrix of expression values, data was input with the rows
accounting for the genomic features, otherwise known as genes, and the columns
corresponding to RNA samples. However, if any problems arise with how data is plugged in, it is
possible for limma to accept results, specifically the DGE list, from edgeR so that the analysis
may be properly run.

II.7 PoissonSeq
PoissonSeq is an R package for RNA-sequencing data, implementing statistical methods
like normalization, estimation of false discovery rate, and testing to recall a list of significant
genes as well as a list for the possibility of a false discovery. Like the binomial distribution, the
Poisson distribution is discrete; however, the distribution only has a single parameter, which is
composed of both the mean and the variance. The Poisson distribution gives a good
approximation to binomial distribution when the sample size, n, is larger (Larget, 2005). In
general, the usage of PoissonSeq can be quite useful in data analysis as it can be used not only
for data with two types of outcomes, but also for data with multiple-class outcomes. Doing so
provides a more complete sense of comparison. PoissonSeq uses the Poisson goodness-of-fit
test to estimate sequence depth (Li, 2011). Sequencing depth, which not only characterizes the
importance of inference data founded on sequencing data but also serves as a scaling factor
between experiments, may be estimated through the implementation of PoissonSeq.
7

II.8 Statistical Analysis of the Differential Expressed Genes
Each RNA-Seq statistical tool resulted in their own respectable selective number of
DEGs. The lists of DEGs from each software were then integrated into new data sets that were
then analyzed with R to compute the q-values. Originally, p-values were obtained for
comparison; however, because each software package contain different normalization factors
that need to be taken into consideration, the p-values were converted to q-values to justly
compare.
Often in statistical analysis, there will be the possibility of obtaining a false positive due
of chance. The false discovery rate (FDR) refers to a proportion of false positives that are
expected among the hypotheses of significance, or the likelihood of a gene to be deemed falsely
positive among the entire pool of significant genes (Nonlinear Dynamics, n.d). Q-values use an
FDR method to adjust p-values, resulting in fewer false positives. For example, a q-value of 0.01
suggests that 1% of significant tests will actually result in a false positive. Therefore, q-values
were used because fewer false positives result with q-values.
The goal of differential analysis is to figure out what could be involved in the biological
process of interest by finding compounds and molecular events that show a great quality of
difference between experimental groups. Therefore, a q-value of 0.05 was used as the cut-off.
Later, a cut-off q-value of 0.01 was used in order to be more selective.

II.9 Visualization and Ingenuity Pathway Analysis
Once the q-values were set, the lists of DEGs used for the comparison were finalized.
The identified DEGS from each analytical tool were then subject to comparison using
InteractiVenn (Heberle et al, 2015). Comparisons were made between overexpressed Atoh1
8

induced mice and the control, the expression of Ptch1+/- mice and the control, as well as the two
groups of mice with the tumors (Atoh1 vs. Ptch1+/-). Using this program results in the number
and the identity of DEGs shared between each RNA-Seq tool and between different conditions,
thus narrowing in on what genes, or as equally important, what pathways may be affected in
the grand scheme of metastatic tumor formation of medulloblastoma with the overexpression
of Atoh1 or Ptch1+/-.
In order to analyze, integrate, and interpret the omics data, Ingenuity Pathway Analysis
(IPA) was applied (QIAGEN®, 2017). Using IPA allowed us to return gene pathways that were
significantly enriched within each group of DEGs. IPA, through powerful analysis, identifies
targets or biomarkers of biological systems and reveals the significance of the data. The program
is able to do so through algorithms that discover mechanisms, functions, and pathways that are
relevant to those changes being observed in an analyzed dataset. IPA also makes use of
BioProfiler, a component identifying potential therapeutic targets by surfacing molecules
relevant to the disease of interest or the phenotype of interest (QIAGEN®, 2017). The IPA
analysis provides a greater interpretation of the impact DEGs have on phenotypic effects.

II.10 Comparative Analysis of Metastatic Medulloblastoma between Mus musculus
and Homo sapiens
Comparative genomics allows researchers to compare the genomic features of different
organisms to one another. In this project, comparative analysis was performed between tumor
samples obtained from humans and mice as a way to explore the potential affected genes that
may be similar or different among the different subgroups. A large cohort of primary
medulloblastoma samples that was uploaded to the National Center for Biotechnology
Information (NCBI) website by The Hospital for Sick Children in Toronto, Canada was obtained
9

from NCBI under Accession number GSE85212 for a comparative genomic analysis (Cavalli et al,
2017). Comparative genomics allowed us to study the biological similarities and differences
between humans and mice and can be used as a way to understand the underlying causes of
disease formation. This cohort dataset consists of a total of 763 samples comprised of the four
distinct subgroups of medulloblastoma: WNT, SHH, Group 3, and Group 4. The samples were
divided into their respective subtypes and an ANOVA test was used to identify the significant
differentially expressed genes. After the DEGs of each subgroup were returned, the genes were
integrated for comparison to study the degree of overlap between the tumor subgroups and
later the overlap between mice and humans.

III. Results
III.1 Comparisons of DEGs returned by the statistical tools
Statistical analysis is important to understanding how phenotypes are affected by
molecular and cellular mechanisms as the analysis is able to detect DEGs between different
conditions. As mentioned in section II, six methods of statistical methods for RNA-Seq data were
applied, each resulting in their respectable amount of DEGs identified. The DEGs from each
package were then placed into the InteractiVenn program to be compared to one another on
the basis of their experimental conditions (Heberle, 2015).
We have created Venn diagrams representing the shared DEGs between the transgenic
Atoh1 model and the control (Figure 1, Figure 4), between the Ptch1+/- model and the control
(Figure 2, Figure 5), and between the transgenic Atoh1 model and the Ptch1+/- model (Figure 3,
Figure 6). As we have previously known, there are similarities and differences between the two
tumor groups and the control group. Observing the Venn diagrams confirms our thoughts even
more as they show a great number of DEGs were identified between the Atoh1 model and the
10

control, the Ptch1+/- model and the control, but relatively few DEGs between the Ptch1+/- model
and the Atoh1 model. This information suggests that metastatic tumors and primary tumors are
similar to each other for they retain similar gene expression profiles
Originally, DEGS were identified using a q-value of less than 0.05; however, the value
was decreased to a cut-off of 0.01 in order to be more precise.

Figure 1: Venn diagram presenting the comparison of DEGs between transgenic mice models
Atoh1 and wild-type mice. DEGs were obtained from the previously mentioned six RNA-Seq
statistical analysis tools. Results are from those DEGs with a q-value<0.05.
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Figure 2: Venn diagram showing the comparison of DEGs between transgenic mice models
Ptch1+/- and wild-type mice. DEGs were obtained from the previously mentioned six RNA-Seq
statistical analysis tools. Results are from those DEGs with a q-value<0.05.

Figure 3: Venn diagram displaying the comparison of DEGs between transgenic mice models
Atoh1 and Ptch1+/-. DEGs were obtained from the previously mentioned six RNA-Seq statistical
analysis tools. Results are from those DEGs with a q-value<0.05.
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Figure 4: Venn diagram presenting the comparison of DEGs between transgenic mice models
Atoh1 and wild-type mice. DEGs were obtained from the previously mentioned six RNA-Seq
statistical analysis tools. Results are from those DEGs with a q-value<0.01.

Figure 5: Venn diagram showing the comparison of DEGs between transgenic mice models
Ptch1+/- and wild-type mice. DEGs were obtained from the previously mentioned six RNA-Seq
statistical analysis tools. Results are from those DEGs with a q-value<0.01.
13

Figure 6: Venn diagram displaying the comparison of DEGs between transgenic mice models
Atoh1 and Ptch1+/-. DEGs were obtained from the previously mentioned six RNA-Seq statistical
analysis tools. Results are from those DEGs with a q-value<0.01.

III.2 Implementation of ChIP-Seq and the comparison of DEGs between the
transcriptome and targetome
For this study, we desired not only to understand how the transcriptome is affected in
MB, but also how the tumor affects the targetome. Therefore, ChIP-Seq was applied. ChIP-Seq
captures DNA targets for transcription factors across the entire genome of any organism and
reveals gene regulatory networks with RNA sequencing (Illumina, 2015). After ChIP-Seq was run
and significant genes were found, the observed data were placed into a comparison with the
data from the transcriptome, originating from the RNA-Seq analyses previously conducted, in
order to better understand the cascade of the cancer.
Primarily, the data obtained for ChIP-Seq were organized by ATOH1 targets in the
metastatic tumor and the ATOH1 targets in the primary tumor and thus, were compared to one
another to get a general sense of what ChIP-Seq originally discovered (Figure 7). Through this
14

comparison, we found 1446 DEGs were shared between the two tumors. ChIP-Seq data, as
mentioned above, was then incorporated into the comparison from the DEGs of RNA-Seq. In
order to carry out this procedure, two of the RNA-Seq packages were dropped using the false
discovery rate calculated by the number of unique genes of the package divided by the total
𝑈

number of genes, or 𝑇 . By calculating the FDR of each package using that expression, limma and
Cuffdiff were exempted from the analysis with the ChIP-Seq as they provided the highest
number of false positives. When ChIP-Seq data was added, it resulted similarly to the outcomes
from the transcriptome analysis. Many genes were significant between the metastatic tumor
and the control (Figure 9), the primary tumor and the control (Figure 8), while few genes were
found between the two tumors (Figures 10-12).

Figure 7: Venn diagram displaying the comparison between two sets of ATOH1 associated genes
in the metastatic tumor group and the primary tumor group of medulloblastoma. The genes
used were the results from ChIP-Seq.
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Figure 8: Venn diagram showing the comparison of DEGs from RNA-Seq (involved with the
transcriptome) and of ChIP-Seq (involved with the targetome) between mice models Ptch1+/and the control.

Figure 9: Venn diagram presenting the comparison of DEGs from RNA-Seq (involved with the
transcriptome) and of ChIP-Seq (involved with the targetome) between transgenic mice models
Atoh1 and the control.
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Figure 10: Venn diagram showing the comparison of DEGs from RNA-Seq (involved with the
transcriptome) and of ChIP-Seq (involved with the targetome) between transgenic mice models
Atoh1 and Ptch1+/-. The ChIP-Seq data used was that of the primary tumor.

Figure 11: Venn diagram showing the comparison of DEGs from RNA-Seq (involved with the
transcriptome) and of ChIP-Seq (involved with the targetome) between transgenic mice models
Atoh1 and Ptch1+/-. The ChIP-Seq data used was that of the metastatic tumor.
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Figure 12: Venn diagram displaying shared DEGs from the Transcriptome and Targetome from
both the primary tumor and the metastatic tumor among different tools.

III.3 Comparison of Transcriptome and Targetome between the metastatic tumor and
the primary tumor with Pathway Analysis
To understand the genetic effects medulloblastoma has, it is critical to run an analysis
between the tumors using both transcriptome and targetome data. Doing so provides a general
overview of the genes commonly affected as well as the function of such genes as pathways
become compromised. Here, we propose comparing the primary tumor vs. the control and the
metastatic tumor vs. the control with one another using the results from the analysis of the
transcriptome (RNA-Seq) and the results from the analysis of the targetome (ChIP-Seq) that
were obtained (Figure 13). A comparison using different sets of DEGs obtained from different
tools provides true differentially expressed genes. From each tool used in this analysis, we also
compared the pathways found to be enriched by IPA (QIAGEN®, 2017). Comparing enriched
pathways provides information on the overlap and differences between the two tumors and is
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biologically meaningful as enriched pathways signify biological functions or processes (Figure
14). Because biological information is provided by pathways, interpretation of the overlap of
enriched pathways provides insight to the molecular cascade of the cancer. Genes and pathways
can be incorporated into a disease and developmental function table signifying their roles in the
development of the disease (Figure 15). From Figure 14, 202 enriched pathways were identified
among the transcriptome and targetome of the two tumors.
Using Figures 13 and 14, we suggest that gene set analysis through IPA has more
strengths to discover hypotheses deemed to be biologically significant. This is indicated in Table
1 as the number of EPs is significantly reduced compared to the number of DEGs.

Figure 13: Venn diagram representing the difference between the primary and metastatic
tumors. DEGs identified in the Transcriptome and Targetome of transgenic mice model Ptch1+/vs. the control and transgenic mouse model Atoh1 vs. the control. Only edgeR, DESeq, and ChIPSeq were used.
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Figure 14: Venn diagram presenting the shared enriched pathways between three tools in both
transgenic mouse model Ptch1+/- vs. the control and transgenic mouse model Atoh1 vs. the
control.
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# of DEGs

# of Unique

Ratio of

DEGs

Unique DEGs

# of EPs

# of Unique

Ratio of

EPs

Unique EPs

(%)
ChIP-Seq

(%)

1665

140

8.41

366

13

3.55

2828

981

34.69

404

18

4.66

4563

29

0.64

388

1

0.26

3874

13

0.34

411

5

1.22

6380

998

15.64

417

8

1.92

5233

451

8.62

441

7

1.59

(Primary)
ChIP-Seq
(Metastatic)
DESeq
(Primary)
DESeq
(Metastatic)
edgeR
(Primary)
edgeR
(Metastatic)
Table 1: Unique DEGs and enriched pathways (EPs) in Primary and Metastatic Tumors models
compared to the control. The DEGs and the EPs were observed among three statistical analysis
tools.
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Figure 15: A Disease and Developmental Function table affected by DEGs identified by edgeR in
MB Metastatic Tumor vs. the control. The darker violet represents more gene involvement.

III.4 Comparative Genomic Analysis of Medulloblastoma for Homo sapiens and Mus
musculus
Because MB is complex with its separation into subgroups, each subgroup has to be
taken into consideration in order to properly understand the molecular and cellular events that
are occurring and that are affected by overexpression. An ANOVA analysis was performed on
the data obtained for each subgroup to acquire the respective differentially expressed genes.
For each tumor group, the top 1000 genes (based on the relative q-values) were selected for
comparison to the rest of the groups (Figure 16).
In the first evaluation, the results of each subgroup from the human primary tumors
were compared to one another and results indicated zero intercorrelated genes, suggesting
heterogeneity as characterized by each of the subgroups having discrete somatic aberrations,
activated pathways, and clinical outcomes. The SHH Mus musculus data was then integrated
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into the comparison for a second evaluation to figure out any possible overlap between Mus
musculus and Homo sapiens (Figure 17). Although there was overlap between three or four of
the five types included in this study, there were zero DEGs common among all five.
We then decided to observe the similarities and differences of the DEGs in Homo
sapiens and Mus musculus categorized under the SHH group. Looking at Figure 18, 142 similar
DEGs were uncovered. These genes were loaded into IPA to reveal the enriched pathways
(Figure 19), which can provide reference for future research.

Figure 16: Venn diagram presenting the top 1000 returned medulloblastoma DEGS within the
different subgroups.
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Figure 17: Venn diagram presenting the top 1000 returned medulloblastoma DEGS within the
different subgroups in human data with the addition of mouse data.

Figure 18: Venn diagram showcasing the Top 1000 returned DEGs in the SHH subgroup of
medulloblastoma found in Homo sapiens and in the SHH subgroup of medulloblastoma found in
Mus musculus.
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Figure 19: Enriched Canonical Pathways in DEGs identified from the overlap between the SHH
subgroup in Homo sapiens and in Mus musculus.
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IV. Conclusion and Discussion
Observing all the Venn diagrams shows that each statistical tool has its own advantages
and limitations as each resulted in not only a different amount of DEGs, but also a variation in
the overlap of DEGs. Therefore, to obtain as accurate results as possible, multiple tools have to
be used when performing an integrative analysis as no single statistical tool can be ruled a
favorite and outed as the best.
Overall, baySeq discovers the fewest number of DEGs for the Atoh1 and wild type
comparison, DESeq detects the smallest amount of DEGs for the Ptch1+/- and wild type
comparison, and limma reveals the greatest amount of DEGs in both. While limma does discover
the largest amount of DEGs, as seen in the Venn diagrams, there are quite a few DEGs not
discovered within the other packages, thus resulting in no overlap for those genes. PoissonSeq
and Cuffdiff also tend to retain unique DEGs. Meanwhile, baySeq, DESeq, and edgeR share the
most DEGs with all the other methods, resulting in very close to 100% of their DEGs being
shared.
𝑈
𝑇

Using the expression , where U stands for the number of unique genes of the package
and T refers to the total number of genes, the FDR value for each statistical package was
calculated. This method was applied to the data from q-values less than 0.05. In the comparison
between the Ptch1+/- model and the wild-type model, baySeq resulted in an FDR of 0%, Cuffdiff
with 5.8%, DESeq with 0%, edgeR with approximately 0%, limma with 7.6% and PoissonSeq with
5.6% FDR. The comparison between the Atoh1 and wild-type models had similar results, with
only limma and PoissonSeq increasing their values (baySeq had 0%, Cuffdiff had 0.055%, DESeq
had approximately 0%, edgeR had 0%, limma had 14% and PoissonSeq had 8.9%). From this
information, we determined to exempt limma and PoissonSeq from analysis with the targetome
because of their high FDR values, thus making room for the ChIP-Seq data.
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ChIP-Seq data was added to the respective comparison for each experimental condition.
We found 332 common DEGs identified by all the packages among the comparison between the
primary tumor vs. the control groups (Figure 8) and 423 common DEGs identified for the
metastatic tumor vs. the control (Figure 9). We observed that the ratio of uniquely identified
DEGS is consistently low when the RNA analysis tools DESeq and edgeR were used, making them
seem somewhat stronger than the other methods. Therefore, we used the data from those two
packages as incentive to compare the transcriptome and targetome even further between the
metastatic tumor and the primary tumor. When we analyzed the two tumors together, with
their respective differences from the control, we detected 231 shared DEGs (Figure 13). The
pathways from each statistical tool were obtained and compared. As seen in Figure 14, 202
similar pathways were revealed to be enriched. Looking at these pathways may give us better
information about the targets and the effects of MB.
Applying comparative genomics to this study allowed us to study the biological
similarities and differences between humans and mice, which could then help us apprehend the
underlying causes of disease formation for MB. Part of the project was to organize human data
into their respective subgroups (WNT, SHH, Group 3, and Group 4) to then be applied to the
data we obtained from our mice models. While we were hoping to find DEGs shared between all
the subgroups of MB, the analysis came back with zero similarities among all subgroups.
Analyzing the subgroups to one another first confirmed our thoughts to the complexity of the
development of the disease and suggests heterogeneity. This is thought to be the case as each
type of MB has its own discrete somatic aberrations, activated pathways, and clinical outcomes;
however, when we compared the SHH subgroup from both the human data and the mouse
data, we detected 142 shared DEGs (Figure 18). Detailed investigation to these genes and their
pathways will provide the next step in our research.
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We have focused on the integrative and comparative analysis of transcriptome and
targetome data for medulloblastoma, while also adding the component of comparative analysis
between two species. By doing so, we have examined the molecular mechanisms of the cancer
and have obtained hypotheses relating to the biological problem itself, thus pointing us in the
next step forward. For example, we identified a set of genes that may contribute to the
metastasis of medulloblastoma and we determined potential pathways and targets that may be
involved in the development of the cancer. The purpose of the latter part of the project was to
detect the similarities and differences in the gene expressions and cellular pathways affected in
the different tumor subgroups and the similarities and differences in the gene expressions and
cellular pathways targeted by the cancer in Mus musculus and Homo sapiens. Comparative
analysis elucidates the dissimilarities between the respective subgroups and organisms, though
the extent of similarities are still in need of further investigation
The future plan of this project will be to create a network visualization of the obtained
results. Afterwards, we will investigate the data of other subgroups of MB cancer and run RNASeq analysis for the other subgroups in a similar fashion. Finally, we will perform a comparative
study among all MB subgroups to reveal the molecular and cellular mechanisms for the overall
formation of MB. Since the tumor data of humans was obtained from primary tumors, a further
step in this research would be to attain gene expression data for metastatic tumors in human
samples and perform a comparative analysis between the primary and metastatic tumors of
Homo sapiens and Mus musculus. Doing so may enlighten development of a safer and more
effective therapy.
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